JPWO2020257145A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020257145A5 JPWO2020257145A5 JP2021574283A JP2021574283A JPWO2020257145A5 JP WO2020257145 A5 JPWO2020257145 A5 JP WO2020257145A5 JP 2021574283 A JP2021574283 A JP 2021574283A JP 2021574283 A JP2021574283 A JP 2021574283A JP WO2020257145 A5 JPWO2020257145 A5 JP WO2020257145A5
- Authority
- JP
- Japan
- Prior art keywords
- stereoisomer
- acceptable salt
- pharmaceutically acceptable
- compound
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/091712 | 2019-06-18 | ||
| CN2019091712 | 2019-06-18 | ||
| US202063035381P | 2020-06-05 | 2020-06-05 | |
| US63/035,381 | 2020-06-05 | ||
| PCT/US2020/037853 WO2020257145A1 (en) | 2019-06-18 | 2020-06-16 | Pyrazolopyrimidine sulfone inhibitors of jak kinases and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022537964A JP2022537964A (ja) | 2022-08-31 |
| JPWO2020257145A5 true JPWO2020257145A5 (de) | 2023-06-22 |
Family
ID=71575774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021574283A Pending JP2022537964A (ja) | 2019-06-18 | 2020-06-16 | Ｊａｋキナーゼのピラゾロピリミジンスルホン阻害剤およびその使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11453671B2 (de) |
| EP (1) | EP3986901A1 (de) |
| JP (1) | JP2022537964A (de) |
| KR (1) | KR20220024405A (de) |
| CN (1) | CN114008051A (de) |
| AU (1) | AU2020297415A1 (de) |
| BR (1) | BR112021025618A2 (de) |
| CA (1) | CA3140024A1 (de) |
| CL (1) | CL2021003341A1 (de) |
| CO (1) | CO2022000118A2 (de) |
| CR (1) | CR20210661A (de) |
| IL (1) | IL288957A (de) |
| MA (1) | MA56518A (de) |
| MX (1) | MX2021015319A (de) |
| PE (1) | PE20220577A1 (de) |
| TW (1) | TW202115068A (de) |
| WO (1) | WO2020257145A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023218484A1 (en) | 2022-05-11 | 2023-11-16 | Pi Industries Ltd. | Bicyclic compounds and their use as pest control agents |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
| US5543523A (en) | 1994-11-15 | 1996-08-06 | Regents Of The University Of Minnesota | Method and intermediates for the synthesis of korupensamines |
| US6034057A (en) | 1995-07-06 | 2000-03-07 | Zeneca Limited | Peptide inhibitors of fibronectine |
| US6248713B1 (en) | 1995-07-11 | 2001-06-19 | Biogen, Inc. | Cell adhesion inhibitors |
| YU25500A (sh) | 1999-05-11 | 2003-08-29 | Pfizer Products Inc. | Postupak za sintezu analoga nukleozida |
| GB0028383D0 (en) | 2000-11-21 | 2001-01-03 | Novartis Ag | Organic compounds |
| EP1241176A1 (de) | 2001-03-16 | 2002-09-18 | Pfizer Products Inc. | Purinderivate zur Behandlung von Ischämie |
| WO2003053930A1 (en) | 2001-12-20 | 2003-07-03 | Bayer Healthcare Ag | 1,4-dihydro-1,4-diphenylpyridine derivatives |
| SE0302487D0 (sv) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
| GB0502258D0 (en) | 2005-02-03 | 2005-03-09 | Argenta Discovery Ltd | Compounds and their use |
| CN101616921A (zh) * | 2007-01-30 | 2009-12-30 | 比奥根艾迪克Ma公司 | 1-H-吡唑并(3,4b)嘧啶衍生物及其作为有丝分裂激酶调节剂的用途 |
| CA2676665A1 (en) * | 2007-01-30 | 2008-08-07 | Biogen Idec Ma Inc. | Modulators of mitotic kinases |
| BRPI0910021A2 (pt) | 2008-06-20 | 2015-09-01 | Genentech Inc | "composto, composição farmacêutica, método para tratar ou atenuar a gravidade de uma doença ou condição responsiva à inibição da atividade jak2 quinas em um paciente, kit para o tratamento de uma doença ou distúrbio responsivo à inibição da jak quinase" |
| EP2348860B1 (de) * | 2008-10-31 | 2015-05-27 | Genentech, Inc. | Pyrazolopyrimidin-jak-hemmer-verbindungen und entsprechende verfahren |
| UA110324C2 (en) * | 2009-07-02 | 2015-12-25 | Genentech Inc | Jak inhibitory compounds based on pyrazolo pyrimidine |
| US8575336B2 (en) | 2011-07-27 | 2013-11-05 | Pfizer Limited | Indazoles |
| KR20150079968A (ko) | 2012-11-09 | 2015-07-08 | 자코버스 파마슈티컬 컴패니, 인코포레이티드 | 헤테로아릴 유도체 및 그의 용도 |
| CA2948589A1 (en) | 2014-05-23 | 2015-11-26 | F. Hoffmann-La Roche Ag | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds which are jak inhibitors |
| TW201720828A (zh) | 2015-11-23 | 2017-06-16 | 赫孚孟拉羅股份公司 | 治療性化合物及組合物以及其使用方法 |
| CN108473501B (zh) | 2016-02-18 | 2021-07-16 | 豪夫迈·罗氏有限公司 | 治疗化合物、其组合物及使用方法 |
| KR20190100337A (ko) | 2016-12-29 | 2019-08-28 | 에프. 호프만-라 로슈 아게 | 피라졸로피리미딘 화합물 및 이의 사용 방법 |
| EP3596072B1 (de) | 2017-03-14 | 2022-06-22 | F. Hoffmann-La Roche AG | Pyrazolochlorophenylverbindungen, zusammensetzungen und verfahren zur verwendung davon |
| CN110678467B (zh) | 2017-05-22 | 2023-06-13 | 豪夫迈·罗氏有限公司 | 治疗化合物和组合物及其使用方法 |
| BR112019024322A2 (pt) | 2017-05-22 | 2020-06-16 | F. Hoffmann-La Roche Ag | Compostos e composições terapêuticos e métodos de uso dos mesmos |
| JP7339263B2 (ja) | 2018-01-15 | 2023-09-05 | エフ． ホフマン－ラ ロシュ アーゲー | Ｊａｋ阻害剤としてのピラゾロピリミジン化合物 |
| CN114008050A (zh) | 2019-06-18 | 2022-02-01 | 豪夫迈·罗氏有限公司 | Jak激酶的吡唑并嘧啶芳基醚抑制剂及其用途 |
| TW202115069A (zh) | 2019-06-18 | 2021-04-16 | 瑞士商赫孚孟拉羅股份公司 | Ｊａｋ激酶之經四唑取代之吡唑并嘧啶抑制劑及其用途 |
-
2020
- 2020-06-16 WO PCT/US2020/037853 patent/WO2020257145A1/en unknown
- 2020-06-16 CA CA3140024A patent/CA3140024A1/en active Pending
- 2020-06-16 AU AU2020297415A patent/AU2020297415A1/en not_active Abandoned
- 2020-06-16 EP EP20739492.5A patent/EP3986901A1/de active Pending
- 2020-06-16 PE PE2021002182A patent/PE20220577A1/es unknown
- 2020-06-16 BR BR112021025618A patent/BR112021025618A2/pt unknown
- 2020-06-16 CN CN202080044750.2A patent/CN114008051A/zh active Pending
- 2020-06-16 KR KR1020227000044A patent/KR20220024405A/ko active Search and Examination
- 2020-06-16 US US16/902,499 patent/US11453671B2/en active Active
- 2020-06-16 MA MA056518A patent/MA56518A/fr unknown
- 2020-06-16 CR CR20210661A patent/CR20210661A/es unknown
- 2020-06-16 JP JP2021574283A patent/JP2022537964A/ja active Pending
- 2020-06-16 MX MX2021015319A patent/MX2021015319A/es unknown
- 2020-06-16 TW TW109120272A patent/TW202115068A/zh unknown
-
2021
- 2021-12-13 IL IL288957A patent/IL288957A/en unknown
- 2021-12-14 CL CL2021003341A patent/CL2021003341A1/es unknown
-
2022
- 2022-01-12 CO CONC2022/0000118A patent/CO2022000118A2/es unknown
- 2022-08-24 US US17/821,851 patent/US20230016791A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4614884B2 (ja) | ピリドンの誘導体とその使用 | |
| JP2001504130A (ja) | キサンチン類およびこれらの治療的使用 | |
| JP2011506412A5 (de) | ||
| CA2633633C (fr) | Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation | |
| JP2010516702A5 (de) | ||
| JP2011527675A5 (de) | ||
| JPH09507219A (ja) | α−２−アドレノセプター作動剤として有用な７−（２−イミダゾリニルアミノ）キノリン化合物 | |
| JP2014525426A5 (de) | ||
| KR20080017296A (ko) | 면역 조절제 활성을 갖는 화합물 | |
| JP2007501280A (ja) | 新規医薬組成物を用いた免疫調節 | |
| CN108698991B (zh) | 2-氧代吲哚化合物 | |
| JPWO2020257145A5 (de) | ||
| US20210137905A1 (en) | 1-piperidinepropionic acid for treating a fibrosing disease | |
| JP2019516765A5 (de) | ||
| RU2021135067A (ru) | Пиразолопиримидинсульфоновые ингибиторы jak-киназ и их применение | |
| JP2013518061A5 (de) | ||
| US20230416292A1 (en) | 5'-O-Phenylacetyluridine and therapeutic use | |
| US11225459B2 (en) | Substituted bisphenylalkylurea compounds and methods | |
| US20190151283A1 (en) | NON-STEROIDAL SELECTIVE GLUCOCORTICOID RECEPTOR AGONISTIC MODULATORS (SEGRAMs) AND USES THEREOF | |
| US11179363B2 (en) | Non-steroidal selective glucocorticoid receptor agonistic modulators (SEGRAMs) and uses thereof | |
| JP2012528184A5 (de) | ||
| WO2015158299A1 (zh) | 磺酰胺类化合物在气道慢性炎症性疾病中的应用 | |
| RU2308272C1 (ru) | Лекарственная композиция, обладающая антиаллергическим и противовоспалительным действием | |
| JP2002520364A (ja) | 治療方法 | |
| KR20170005539A (ko) | 디피리다몰을 유효 성분으로 함유하는 신장 질환 치료용 의약 조성물 |